Omnix Medical is a clinical company, dedicated to the development and commercialization of highly effective antibiotic agents against resistant pathogenic bacterial strains, a highly common problem in today's medicine especially in chronic conditions and in modern hospitals. These agents are based on natural antimicrobial peptides, genetically engineered to be compatible for therapeutic use. Omnix is addressing an enormous and rapidly growing market opportunity, represented by millions of Americans and many more millions worldwide, who suffer from infections associated with resistant bacteria.
Location: Israel
Employees: 11-50
Total raised: $25M
Founded date: 2015
Investors 1
| Date | Name | Website |
| - | Tal Ventur... | tal-ventur... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 16.10.2025 | Series C | $25M | European I... |
Mentions in press and media 2
| Date | Title | Description |
| 16.10.2025 | Harel Insurance backs Omnix Medical | Jerusalem-based biopharmaceutical company Omnix Medical Omnix Medical Founded: 2015 Headquarters: Jerusalem, Yerushalayim, Israel Total Funding: $39.02M See full company profile "> has raised $25 million in a Series C funding round ... |
| - | Omnix Medical | “Bringing The Next-Generation Of Antibiotics to win the war against resistant bacteria Learn More About Our Technology Our Vision Omnix Medical is dedicated to the development and commercialization of highly effective antibiotic agents agai... |